Bomedemstat vs Hydroxyurea for Essential Thrombocythemia (MK-3543-007)

Trial Identifier: 3543-007
Sponsor: MSD
Start Date: July 2024
Primary Completion Date: May 2029
Study Completion Date: May 2029
Condition: Blood Disorder

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description
Protocol Plain Language Summary - English
Protocol Plain Language Summary - English
Protocol Plain Language Summary – English

Trial Locations

Country Location
Australia, South Australia Adelaide, South Australia, Australia, 5000
Chile, Biobio Concepcion, Biobio, Chile, 4070196
Chile, Coquimbo La Serena, Coquimbo, Chile, 1720430
Chile, Region M. de Santiago Santiago, Region M. de Santiago, Chile, 7580206
Chile, Region M. de Santiago Santiago, Region M. de Santiago, Chile, 8420383
Chile, Region M. de Santiago Santiago, Region M. de Santiago, Chile, 7650568
Hong Kong, N/A HKSAR, N/A, Hong Kong, N/A
Israel, N/A Haifa, N/A, Israel, 3109601
Israel, N/A Jerusalem, N/A, Israel, 9112001
Israel, N/A Ramat Gan, N/A, Israel, 5265601
Israel, N/A Zerifin, N/A, Israel, 7033001
Japan, Ehime Toon, Ehime, Japan, 791-0295
Japan, Fukuoka Fukuoka, Japan, 812-8582
Japan, Fukushima Fukushima, Japan, 960-1295
Japan, Hokkaido Sapporo, Hokkaido, Japan, 060-8648
Japan, Hyogo Kobe, Hyogo, Japan, 650-0047
Japan, Ishikawa Kanazawa, Ishikawa, Japan, 920-8641
Japan, Mie Tsu, Mie, Japan, 514-8507
Japan, Miyagi Sendai, Miyagi, Japan, 983-8520
Japan, Miyazaki Miyazaki, Japan, 889-1692
Japan, Okayama Okayama, Japan, 700-8558
Japan, Osaka Hirakata, Osaka, Japan, 573-1191
Japan, Osaka Osakasayama, Osaka, Japan, 589-8511
Japan, Tokyo Bunkyo-ku, Tokyo, Japan, 113-8431
Japan, Tokyo Tokyo, Japan, 113-8603
Japan, Yamanashi Chuo, Yamanashi, Japan, 409-3898